Land: Verenigd Koninkrijk
Taal: Engels
Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)
Tacrolimus
Abacus Medicine Ltd
L04AD02
Tacrolimus
1mg
Oral capsule
Oral
No Controlled Drug Status
Caution - AMP level prescribing advised
BNF: 08020200; GTIN: 08719923001804
PROGRAF ® 1 MG CAPSULES (tacrolimus) PATIENT INFORMATION LEAFLET READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. This medication is available using the above name but will be referred to as Prograf throughout the following leaflet. This medicine is available in other strengths. This leaflet also contains information regarding other strengths of Prograf. WHAT IS IN THIS LEAFLET 1. What Prograf is and what it is used for 2. What you need to know before you take Prograf 3. How to take Prograf 4. Possible side effects 5. How to store Prograf 6. Contents of the pack and other information 1. WHAT PROGRAF IS AND WHAT IT IS USED FOR Prograf belongs to a group of medicines called immunosuppressants. Following your organ transplant (e.g. liver, kidney, heart), your body’s immune system will try to reject the new organ. Prograf is used to control your body’s immune response enabling your body to accept the transplanted organ. Prograf is often used in combination with other medicines that also suppress the immune system. You may also be given Prograf for an ongoing rejection of your transplanted liver, kidney, heart or other organ or if any previous treatment you were taking was unable to control this immune response after your transplantation. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE PROGRAF DO NOT TAKE PROGRAF - If you are allergic (hypersensitive) to tacrolimus or any of the other ingredients of Prograf (listed in Section 6). - If you are allergic (hypersensitive) to any antibiotic belonging to the subgroup of macrolide antibiotic Lees het volledige document
PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Not applicable 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Not applicable 3. PHARMACEUTICAL FORM Not applicable 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Not applicable 4.2. POSOLOGY AND METHOD OF ADMINISTRATION Not applicable 4.3. CONTRAINDICATIONS Not applicable 4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE Not applicable 4.5. INTERACTIONS WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Not applicable 4.6. PREGNANCY AND LACTATION Not applicable 4.7. EFFECTS ON ABILITY TO DRIVE AND USE MACHINES Not applicable 4.8. UNDESIRABLE EFFECTS Not applicable 4.9. OVERDOSE Not applicable 5. PHARMACOLOGICAL PROPERTIES 5.1. PHARMACODYNAMIC PROPERTIES Not applicable 5.2. PHARMACOKINETIC PROPERTIES Not applicable 5.3. PRECLINICAL SAFETY DATA Not applicable 6. PHARMACEUTICAL PARTICULARS 6.1. LIST OF EXCIPIENTS Not applicable 6.2. INCOMPATIBILITIES Not applicable 6.3. SHELF LIFE Not applicable 6.4. SPECIAL PRECAUTIONS FOR STORAGE Not applicable 6.5. NATURE AND CONTENTS OF CONTAINER Not applicable 6.6. INSTRUCTION FOR USE AND HANDLING (, AND DISPOSAL) Not applicable No Data Held ADMINISTRATIVE DATA 7. Marketing Authorisation Holder Not applicable 8. MARKETING AUTHORISATION NUMBER Not applicable 9. DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION Not applicable 10. DATE OF (PARTIAL) REVISION OF TEXT Not applicable Lees het volledige document